Huggies maker Kimberly-Clark is buying Tylenol maker Kenvue

Tylenol, which contains acetaminophen, has been astatine nan halfway of a disputed declare that it is linked to autism. Scott Olson/Getty Images North America hide caption

toggle caption

Scott Olson/Getty Images North America

Consumer elephantine Kimberly-Clark, which makes Huggies diapers and Kleenex tissues, is buying nan institution that makes Tylenol and Band-Aids successful 1 of nan biggest mergers of nan year.

The deal, worthy almost $49 billion, comes astatine a peculiarly difficult clip for Tylenol-maker Kenvue, aft nan Trump management linked acetaminophen — nan progressive constituent successful this communal painkiller — to autism. The assertions came contempt a deficiency of clear technological evidence, and Kenvue has called them simply false.

For Kimberly-Clark, nan woody adds a caller swath of user brands. Besides Tylenol, Kenvue besides owns different drugstore mainstays specified arsenic Band-Aid, Listerine, Neutrogena and Aveeno.

Kimberly-Clark CEO Mike Hsu said successful Monday's announcement, that nan 2 "iconic companies" would create "a world wellness and wellness leader."

Executives from some companies said nan mixed entity would service group "at each shape of life" and use from Kenvue's relationships pinch dermatologists, dentists, pediatricians and different healthcare professionals.

Kimberly-Clark has been attempting to situation nan power of user goliath Procter & Gamble, whose business spans each drugstore aisles, including acold and digestion medicines.

And Kenvue has been connected nan trading artifact for a while now, ever since it was spun disconnected from Johnson & Johnson successful 2023. Its stock value collapsed a fewer months aft going public, losing a 3rd of its worth since nan commencement of nan twelvemonth earlier Monday's news.

On Monday morning, Kenvue's banal value jumped astir 17%, while Kimberly-Clark's fell astir 12%.